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Yellow	fever:	is	Asia	prepared	for	an	epidemic?		Annelies	Wilder-Smith,	Vernon	Lee,	Duane	J	Gubler		Epidemic	 arboviral	 diseases	 are	 relentlessly	 increasing,	 fueled	 by	 unplanned	urbanization	 leading	 to	 increased	 breeding	 sites,	 lack	 of	 effective	 disease	 and	vector	control	strategies,	and	globalization	resulting	in	disease	exportation.1	This	decade,	 the	 number	 of	 travelers	 exporting	 yellow	 fever	 virus	 to	 non-endemic	countries	 is	 at	 a	 record	 high.2	 Furthermore,	 in	 2016	 for	 the	 first	 time	 in	documented	 history,	 confirmed	 yellow	 fever	 virus	 was	 exported	 in	 travelers	from	Africa	to	Asia,	where	approximately	2	billion	immunologically-naïve	people	live	 in	areas	 inhabited	by	the	Aedes	aegypti	mosquito	vector	and	are	at	risk	 for	transmission.3	The	case-fatality	 rate	of	yellow	 fever	 is	among	 the	highest	of	all	arboviral	 diseases,	 underscoring	 the	 threat	 of	 a	 newly	 emerging	 epidemic	disease	problem	in	Asia.			Why	outbreaks	of	 yellow	 fever	 have	not	 yet	 occurred	 in	Asia	 is	 unknown.	The	factors	 influencing	 transmission	 dynamics	 of	 yellow	 fever	 (e.g.	 vector	competence,	 magnitude	 and	 duration	 of	 viremia	 in	 humans)	 are	 similar	 to	dengue,	which	aided	by	human	air	travel,	has	spread	around	the	world.	In	recent	decades,	 most	 human	 yellow	 fever	 infections	 have	 occurred	 when	 humans	encroach	the	sylvatic	cycle	outside	urban	areas,	decreasing	the	risk	of	dispersal	via	air	travel.	However,	major	urban	epidemics	have	occurred	in	both	Africa	and	tropical	 America	 in	 the	 past	 3	 years,	 and	 recent	 decades	 have	 seen	 an	unprecedented	 growth	 in	 air	 travel	 intensity	 between	 Africa	 or	 Latin	 America	directly	 to	 Asia.4	 This	 increases	 the	 probability	 that	 travelers	 infected	 with	yellow	 fever	 will	 introduce	 the	 virus	 to	 Asia	 at	 a	 time	 when	 conditions	 are	aligned:	 the	 presence	 of	 Aedes	 mosquitoes	 in	 an	 urban	 area	 during	 a	 suitable	seasonal	 window.	 Application	 of	 the	 International	 Health	 Regulations	 (IHR)	which	require	mandatory	yellow	fever	vaccination	for	all	travellers	from	yellow	fever	 endemic	 areas	 to	 permissive	 non-endemic	 areas	 should	 prevent	 such	introductions.	 However,	 hundreds	 of	 thousands	 of	 persons	 have	 circumvented	the	IHR	as	evidenced	during	the	yellow	fever	outbreak	in	Angola5	which	should	serve	as	a	wake-up	call.		Is	Asia	prepared	for	a	yellow	fever	epidemic?	Many	countries	strengthened	their	pandemic	preparedness	capabilities	in	the	wake	of	the	2009	influenza	pandemic,	guided	by	 the	World	Health	Organization.	 Country	 capacity	 building	under	 the	IHR,	supported	by	the	Joint	External	Evaluation,	has	increased	preparedness	and	response	capabilities	to	a	range	of	public	health	threats.	However,	it	is	uncertain	whether	preparedness	 for	epidemic	vector-borne	diseases	such	as	yellow	fever	has	been	increased.			Among	 the	 key	 issues	 that	 need	 to	 be	 addressed	 are	 the	 strengthening	 of	laboratory-based	 surveillance	 capable	 of	 detecting	 imported	 yellow	 fever,	effective	 vector	 control	 programs,	 and	 plans	 to	 scale-up	 mass-vaccination	programs,	including	the	capacity	to	rapidly	import	vaccines,	training	healthcare	workers	 to	 conduct	 such	 programs,	 and	 clinical	management	 of	 severe	 yellow	fever	disease.	
	We	 advocate	 for	 a	 call	 to	 action	 to	 urgently	 identify	 gaps	 and	 develop	preparedness	plans	in	all	Asia-Pacific	countries	that	are	at	risk	for	yellow	fever	virus	introduction.			References		1.	 Wilder-Smith	 A,	 Gubler	 DJ,	 Weaver	 SC,	 Monath	 TP,	 Heymann	 DL,	 Scott	TW.	 Epidemic	 arboviral	 diseases:	 priorities	 for	 research	 and	 public	 health.	
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